OBJECTIVE:Elevated blood glucose is associated with poor outcome in patients resuscitated from out-of-hospital cardiac arrest (OHCA). Our aim was to determine whether strict glucose control with intensive insulin treatment improves outcome of OHCA patients. DESIGN: A randomized, controlled trial. SETTING:Two university hospital intensive care units. PATIENTS: Ninety patients resuscitated from OHCA with ventricular fibrillation detected as the initial rhythm were treated with therapeutic hypothermia. INTERVENTIONS: Patients were randomized into two treatment groups: a strict glucose control group (SGC group), with a blood glucose target of 4-6 mmol/l, or a moderate glucose control group (MGC group), with a blood glucose target of 6-8 mmol/l. Both groups were treated with insulin infusion for 48 h, because a control group with no treatment was considered unethical. MEASUREMENTS AND RESULTS: Baseline data were similar in both groups. In the SGC group 71% of the glucose measurements were within the target range compared with 41% in the MGC group. Median glucose was 5.0 mmol/l in the SGC group and 6.4 mmol/l in the MGC group. The occurrence of moderate hypoglycemic episodes was 18% in the SGC group and 2% in the MGC group (p = 0.008). No episodes of severe hypoglycemia occurred. Mortality by day 30 was 33% in the SGC group and 35% in the MGC group (p = 0.846); the difference was 2% (95% CI -18% to +22%). CONCLUSIONS: We found no additional survival benefit from strict glucose control compared with moderate glucose control with a target between 6 and 8 mmol/l in OHCA patients.
RCT Entities:
OBJECTIVE: Elevated blood glucose is associated with poor outcome in patients resuscitated from out-of-hospital cardiac arrest (OHCA). Our aim was to determine whether strict glucose control with intensive insulin treatment improves outcome of OHCA patients. DESIGN: A randomized, controlled trial. SETTING: Two university hospital intensive care units. PATIENTS: Ninety patients resuscitated from OHCA with ventricular fibrillation detected as the initial rhythm were treated with therapeutic hypothermia. INTERVENTIONS:Patients were randomized into two treatment groups: a strict glucose control group (SGC group), with a blood glucose target of 4-6 mmol/l, or a moderate glucose control group (MGC group), with a blood glucose target of 6-8 mmol/l. Both groups were treated with insulin infusion for 48 h, because a control group with no treatment was considered unethical. MEASUREMENTS AND RESULTS: Baseline data were similar in both groups. In the SGC group 71% of the glucose measurements were within the target range compared with 41% in the MGC group. Median glucose was 5.0 mmol/l in the SGC group and 6.4 mmol/l in the MGC group. The occurrence of moderate hypoglycemic episodes was 18% in the SGC group and 2% in the MGC group (p = 0.008). No episodes of severe hypoglycemia occurred. Mortality by day 30 was 33% in the SGC group and 35% in the MGC group (p = 0.846); the difference was 2% (95% CI -18% to +22%). CONCLUSIONS: We found no additional survival benefit from strict glucose control compared with moderate glucose control with a target between 6 and 8 mmol/l in OHCA patients.
Authors: J P Nolan; P T Morley; T L Vanden Hoek; R W Hickey; W G J Kloeck; J Billi; B W Böttiger; P T Morley; J P Nolan; K Okada; C Reyes; M Shuster; P A Steen; M H Weil; V Wenzel; R W Hickey; P Carli; T L Vanden Hoek; D Atkins Journal: Circulation Date: 2003-07-08 Impact factor: 29.690
Authors: Salmaan Kanji; Avinder Singh; Michael Tierney; Hilary Meggison; Lauralyn McIntyre; Paul C Hebert Journal: Intensive Care Med Date: 2004-03-20 Impact factor: 17.440
Authors: Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman Journal: Circulation Date: 2010-10-19 Impact factor: 29.690
Authors: Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman Journal: Pediatrics Date: 2010-10-18 Impact factor: 7.124
Authors: Stefan Korsatko; Martin Ellmerer; Lukas Schaupp; Julia K Mader; Karl-Heinz Smolle; Beate Tiran; Johannes Plank Journal: Intensive Care Med Date: 2008-12-05 Impact factor: 17.440
Authors: David G Beiser; Gordon E Carr; Dana P Edelson; Mary Ann Peberdy; Terry L Vanden Hoek Journal: Resuscitation Date: 2009-03-18 Impact factor: 5.262
Authors: Freya M van Iersel; Arjen J C Slooter; Renee Vroegop; Annemiek E Wolters; Charlotte A M Tiemessen; Rik H J Rösken; Johannes G van der Hoeven; Linda M Peelen; Cornelia W E Hoedemaekers Journal: Intensive Care Med Date: 2012-08-21 Impact factor: 17.440